Results 11 to 20 of about 19,123,678 (263)

Does Pentraxin-3 contribute to the reduction of low-density lipoprotein levels by statin therapy? [PDF]

Arhiv za farmaciju, 2022
Statins have been shown to decrease inflammatory markers, especially high sensitivity C reactive protein (hsCRP), in a dose-dependent manner. Pentraxin-3 (PTX3) is another important inflammatory biomarker from the pentraxin family that provides useful ...
Vuković-Dejanović Vesna, Spasojević-Kalimanovska Vesna, Kalimanovska-Oštrić Dimitra, Bogavac-Stanojević Nataša   +3 more
doaj   +1 more source

LDL-C target attainment in the total cohort and stratified by risk as observed and simulated.

, 2022
LDL-C concentrations are given as median (interquartile range). LDL-C: Low-density lipoprotein cholesterol. LLT: Lipid-lowering therapy.
Aikaterini Bilitou (5785471), Ulrich Laufs (360751), Christian Becker (49615), Julius L. Katzmann (10960479)   +3 more
core   +1 more source

LDL-C Targets in Secondary Prevention: How Low Should We Go?

, 2022
The benefits of lowering low-density lipoprotein cholesterol (LDL-C), mainly using high-intensity statin therapy, and its impact on decreasing the recurrence of atherosclerotic cardiovascular disease (ASCVD) in secondary prevention has been well ...
Mohamed B. Elshazly (14151951), Preethi Mani (14151945), Leslie Cho (8859803), Mohammed Gaber (14151942), Donald Clark (14151948), Seth S. Martin (8164878), Rishi Puri (6090599), Karim Bayoumy (3496688), Eoin Donnellan (12122073)   +8 more
core   +1 more source

Nicotine regulates PCSK9 expression in HepG2 cells through Raf/MEK/ERK signaling pathway

陆军军医大学学报, 2023
Objective To investigate the effect of nicotine (NIC) on the expression of proprotein convertase subtilisin/kexin type 9 (PCSK9) and its molecular mechanism.
ZHOU Lin, XIANG Rui, MAO Min, FENG Rui, HU Yuhao   +4 more
doaj   +1 more source

Mathematical model for low density lipoprotein (LDL) endocytosis by hepatocytes [PDF]

, 2008
Individuals with elevated levels of plasma low density lipoprotein (LDL) cholesterol (LDL-C) are considered to be at risk of developing coronary heart disease.
B. O’Malley, J. A. D. Wattis, H. Blackburn, Wattis, JA, H. M. Byrne, L. Pickersgill, O'Malley, B, Panovska, J, Pickersgill, L, Blackburn, H, Byrne, HM, Byrne, Helen, K. G. Jackson, Wattis, JAD, Jackson, KG, J. Panovska, Panovska, J., O'Malley, B., Pickersgill, L., Wattis, J.A.D., Jackson, K.G., Blackburn, H., Byrne, H.M.   +22 more
core   +1 more source

Alternate Day versus Once Daily Atorvastatin for Primary Prevention of (CHD) in Naïve Patients of Dyslipidemia [PDF]

Journal of Clinical and Diagnostic Research, 2014
Introduction: Statins (or HMG-CoA reductase inhibitors) have become drug of choice for raised Low-Density Lipoprotein Cholesterol (LDL-C) in treating.
Canna Jagdish Ghia, Archana Sushil Panda, Linesh R. Khobragade, Rajesh Kumar Jha, Gautam S Rambhad   +4 more
doaj   +1 more source

Comparison between Values of Low Density Lipoprotein Cholesterol as Estimated by Direct Enzymatic Method with Calculated Methods Applying Friedewald’s Equation and Novel’s Equation: A Cross-sectional Study [PDF]

National Journal of Laboratory Medicine, 2022
Introduction: Lipid profile is routinely used as a screening test to identify the risk of Cardiovascular Diseases (CVD). Elevated Low Density Lipoprotein cholesterol (LDL-c) is an important modifiable risk factor of atherosclerotic CVD.
Maithri Chikkabasavanahalli Manjegowda, Raghunath Hanumantharaya, Mythri Sannamadhu, Medhini Nagaranavile Shivaswamy   +3 more
doaj   +1 more source

LDL-C response by 6-month treatment of statin or statin + ezetimibe.

, 2023
LDL-C response by 6-month treatment of statin or statin + ezetimibe.
Joo-Hee Zo (721373), Jae-Bin Seo (721370), Myung-A Kim (721372), Woo-Hyun Lim (6157328), Hack-Lyoung Kim (654343), Sang-Hyun Kim (282188)   +5 more
core   +1 more source

Avaliação da dosagem direta do colesterol-LDL em amostras de sangue de 10.664 pacientes em comparação com o uso da fórmula de Friedewald Comparison of LDL-cholesterol direct measurement with the estimate using the Friedewald formula in a sample of 10,664 patients

Arquivos Brasileiros de Cardiologia, 2004
OBJETIVO: Avaliar a dosagem direta do colesterol LDL (LDL-C) por um método homogêneo, em comparação com a estimativa pela fórmula de Friedewald, em uma grande população heterogênea.
Caio Maurício Mendes de Cordova, Carlos Rudi Schneider, Iara Deise Juttel, Maurício Mendes de Cordova   +3 more
doaj   +1 more source

Platelet interaction with bioactive lipids formed by mild oxidation of low-density lipoprotein [PDF]

, 2006
Oxidation of low-density lipoprotein (LDL) generates pro-inflammatory and pro-thrombotic mediators that play a crucial role in cardiovascular and inflammatory diseases.
Wolfgang Siess, Siess, Wolfgang
core   +1 more source